Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

To define the mechanism(s) responsible for the negative inotropic effects of tumor necrosis factor-alpha (TNF alpha) in the adult heart, we examined the functional effects of TNF alpha in the intact left ventricle and the isolated adult cardiac myocyte. Studies in both the ventricle and the isolated adult cardiac myocyte showed that TNF alpha exerted a concentration- and time-dependent negative inotropic effect that was fully reversible upon removal of this cytokine. Further, treatment with a neutralizing anti-TNF alpha antibody prevented the negative inotropic effects of TNF alpha in isolated myocytes. A cellular basis for the above findings was provided by studies which showed that treatment with TNF alpha resulted in decreased levels of peak intracellular calcium during the systolic contraction sequence; moreover, these findings did not appear to be secondary to alterations in the electrophysiological properties of the cardiac myocyte. Further studies showed that increased levels of nitric oxide, de novo protein synthesis, and metabolites of the arachidonic acid pathway were unlikely to be responsible for the TNF alpha-induced abnormalities in contractile function. Thus, these studies constitute the initial demonstration that the negative inotropic effects of TNF alpha are the direct result of alterations in intracellular calcium homeostasis in the adult cardiac myocyte.

[1]  C. Natanson,et al.  Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. , 1992, The American journal of physiology.

[2]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[3]  F. Murad,et al.  Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. , 1992, Molecular pharmacology.

[4]  P. Allen,et al.  Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. , 1992, Circulation research.

[5]  S. Moncada,et al.  Induction and potential biological relevance of a Ca2+‐independent nitric oxide synthase in the myocardium , 1992, British journal of pharmacology.

[6]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[7]  J. McMurray,et al.  Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. , 1991, British heart journal.

[8]  E. Arbustini,et al.  Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study. , 1991, The American journal of pathology.

[9]  G. Schreiner,et al.  A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of beta-adrenergic responses. , 1991, Circulation.

[10]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[11]  J. Vilček,et al.  Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. , 1991, The Journal of biological chemistry.

[12]  D. Mann,et al.  Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. , 1991, Circulation research.

[13]  J. Larrick,et al.  Cytotoxic mechanism of tumor necrosis factor‐α , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  G. Schreiner,et al.  Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.

[15]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[16]  A. M. Lefer,et al.  Mediation of cardioprotection by transforming growth factor-beta. , 1990, Science.

[17]  T. Mckenna,et al.  Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. , 1990, The Journal of clinical investigation.

[18]  J. Adams,et al.  hypotension: Implications for the involvement of nitric oxide , 2022 .

[19]  O. Nielsen,et al.  Recombinant human tumour necrosis factor increases cytosolic free calcium in murine fibroblasts and stimulates inositol phosphate formation in L-M and arachidonic acid release in 3T3 cells. , 1990, Cellular signalling.

[20]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Kovacs,et al.  The cardiovascular response of normal humans to the administration of endotoxin. , 1989, The New England journal of medicine.

[22]  D. Mann,et al.  Load Regulation of the Properties of Adult Feline Cardiocytes: Growth Induction by Cellular Deformation , 1989, Circulation research.

[23]  C. Natanson,et al.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock , 1989, The Journal of experimental medicine.

[24]  C. Maury,et al.  Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. , 1989, Journal of internal medicine.

[25]  S. Houser,et al.  Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. , 1988, The American journal of physiology.

[26]  D. Kufe,et al.  Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. , 1988, Journal of the National Cancer Institute.

[27]  Harold V. Gaskill Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat. , 1988, The Journal of surgical research.

[28]  P. J. Simpson,et al.  Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. , 1988, Journal of molecular and cellular cardiology.

[29]  K. Spitzer,et al.  A video system for measuring motion in contracting heart cells , 1988, IEEE Transactions on Biomedical Engineering.

[30]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[31]  D. Newell,et al.  In pursuit of evidence based integrated care , 1987, British Journal of Cancer.

[32]  C. Herzog,et al.  [Interleukin 1 and tumor necrosis factor]. , 1987, Zeitschrift fur Rheumatologie.

[33]  M. Rosenblum,et al.  Phase I study of recombinant tumor necrosis factor in cancer patients. , 1987, Cancer research.

[34]  D. Remick,et al.  Acute in vivo effects of human recombinant tumor necrosis factor. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[35]  W. Fiers,et al.  The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. D. Albert,et al.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.

[37]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[38]  H M Piper,et al.  Cell cultures of adult cardiomyocytes as models of the myocardium. , 1986, Journal of molecular and cellular cardiology.

[39]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[40]  S. Houser,et al.  Transmembrane potassium fluxes in isolated feline ventricular myocytes. , 1985, The American journal of physiology.

[41]  D. Goeddel,et al.  Human tumor necrosis factor. Production, purification, and characterization. , 1985, The Journal of biological chemistry.

[42]  W. Claycomb Cardiac muscle cell proliferation and cell differentiation in vivo and in vitro. , 1983, Advances in experimental medicine and biology.

[43]  E Neher,et al.  A patch‐clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. , 1982, The Journal of physiology.

[44]  W. Claycomb,et al.  Ultrastructure of terminally differentiated adult rat cardiac muscle cells in culture. , 1982, The American journal of anatomy.

[45]  N. Blin,et al.  A general method for isolation of high molecular weight DNA from eukaryotes. , 1976, Nucleic acids research.

[46]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.